# AstraZeneca inaugurates €135 million expansion at Dunkerque inhaler plant

AstraZeneca inaugurated a €135 million expansion at its Dunkerque site, adding a new testing laboratory, a third formulation line, a fifth assembly line, and an automated warehouse. The expansion increases capacity for inhaler production.

- Type: Expansion
- Announced: 2019-04-25
- Where: Dunkerque, France
- Value: $151.0M (135.0M EUR)
- Starts operating: 25 Apr 2019
- Status: completed
- Capacity: third formulation line can produce up to 28 million units annually
- Products: aerosol inhalers for respiratory diseases
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [AstraZeneca](https://endata.com/companies/35467.md)

## Sources

- [nordfranceinvest.com](https://www.nordfranceinvest.com/news/astrazeneca-a-fixture-in-hauts-de-france-for-over-25-years/), 2019-04-24: "We decided to make Dunkerque the global gold standard for aerosol delivery devices— which tells you how important this site is to us."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.